JOURNAL ARTICLE
REVIEW
Add like
Add dislike
Add to saved papers

Pediatric combined formulation DTaP-IPV/Hib vaccine.

Combination vaccines have been used for many years in the USA as part of the primary infant immunization series. However, the current program still requires up to 24 injections by 18 months of age. The Advisory Committee on Immunization Practices in the USA recommends the use of combination vaccines whenever possible. A combination vaccine was recently licensed in the USA for the prevention of diphtheria, tetanus, pertussis, polio and Haemophilus influenzae type b (DTaP-IPV/Hib). This product has been used exclusively for childhood immunizations in Canada for the last decade and shown to be safe and effective as part of a primary infant series and toddler booster immunization program. This article summarizes the available safety, immunogenicity and effectiveness data of this combination vaccine and provides a brief review of future trends in combination vaccine use.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app